12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Other News

Prometheus, Mayo Collaborative Services Inc. diagnostic news

The U.S. Supreme Court ruled 9-0 that two patents from Prometheus on the use of biomarkers to help determine a patient's treatment are not eligible for patenting under Section 101 of the Patent Act. The court said in its opinion the claimed...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >